Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
MIST+ is studying a nasal spray to see if it will reduce the need for surgery for snoring.
Children aged 3-12 are invited to take part. Snoring affects up to 10% of children and can
cause sleeping problems and concentration or behavioural issues in the daytime. Currently the
most common treatment for snoring is surgery to remove the tonsils and/or adenoids, however
many children wait a long time to see a specialist. This research is trying to find if nasal
sprays can help children with snoring, and whether this can reduce the need for surgery.